Although NVP-BEZ235 is a more effective strategy to enhance cancer treatment than the inhibition of only TORC1 or PI3K/Akt, the effect of NVP-BEZ235 on apoptosis in renal carcinoma cells is not well characterized. This evidence concerns the gene AKT1 and cancer.